Status:
UNKNOWN
Intraperitoneal Aerosolized Delivery of a Local Anesthetic for Post Operative Pain Management. A Double Blind, Randomised Controlled Clinical Trial.
Lead Sponsor:
Northgate Technologies
Conditions:
Pain, Postoperative
Postoperative Pain
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the effectiveness of aerosolized pain medication (.5% bupivicaine) delivered into the peritoneal cavity after laparoscopic gastric bypass surgery. This double...
Detailed Description
Surgical Technique 1. 30 mls of 0.5% bupivacaine with epinephrine standard dose will be distributed into the trocar site wounds after desufflation of the peritoneal cavity. 2. All the patients will b...
Eligibility Criteria
Inclusion
- Male or female patients between the ages of 18-65
- Patients in general good health requiring elective surgery
Exclusion
- Female patients that are pregnant
- Patients allergic to bupivicaine
- Patients who have used narcotic drugs within 30 days of the surgical procedure.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00286286
Start Date
February 1 2006
End Date
August 1 2006
Last Update
January 11 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexian Brothers Medical Center
Elk Grove Village, Illinois, United States, 60007
2
St. Alexius Medical Center
Hoffman Estates, Illinois, United States, 60194